Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

All‐cause mortality D60 or more · people with mild/moderate/severe/critical COVID‐19

It is very uncertain whether levilimab changes all‐cause mortality D60 or more compared with standard care/placebo (very low certainty).

1 finding from 1 review

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
RR 1 [0.26, 3.89]
1 study · 206 participants
Very low